비교리스트

 카트 문의
시장보고서
상품코드
1566940

생체적합성 코팅 시장 : 유형별, 재료별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Biocompatible Coating Market By Type (Antimicrobial, Hydrophilic, Others) , By Material (Polymer, Ceramic, Metal, Others) By End User (Healthcare, Medical Device, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 260 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생체적합성 코팅 시장은 2023년 134억 달러로 평가되며 2024년부터 2033년까지 연평균 12% 성장하여 2033년에는 414억 달러에 달할 것으로 예상됩니다.

생체적합성 코팅은 의료기기, 임플란트 및 기타 의료 관련 재료에 적용되어 인체의 생물학적 환경과의 호환성을 보장하는 생체 재료입니다. 이러한 코팅은 기기와 주변 조직과의 조화로운 상호 작용을 촉진하여 염증 및 거부 반응과 같은 부작용을 최소화하도록 설계되었습니다. 녹 방지, 내마모성, 생물학적 활성 등의 특성을 부여하여 의료용 임플란트의 성능과 수명을 향상시켜 의료 기술의 발전과 환자 결과 개선에 필수적인 역할을 하고 있습니다.

세계 생체적합성 코팅 시장의 성장은 노인 인구의 급증과 만성 질환의 유병률 증가로 인해 정형외과, 치과, 심혈관 장치 등 의료용 임플란트에 대한 수요가 증가하고 있으며, 이러한 의료용 임플란트는 생체와의 안전하고 효과적인 통합을 위해 생체적합성 코팅이 필요하기 때문입니다. 생체적합성 코팅을 필요로 합니다. 또한, 감염 및 임플란트 거부반응과 같은 합병증 위험 감소에 대한 관심이 높아지면서 의료기기의 안전성과 적합성을 향상시키는 생체적합성 코팅의 채택을 촉진하고 있습니다. 또한, 제약 부문의 확대와 약물전달 시스템에 대한 수요가 급증하면서 의약품 활성 성분의 제어된 방출과 안정성을 보장하기 위해 생체적합성 코팅이 필요하게 되었고, 이는 시장 성장에 기여하고 있습니다. 또한, 의료용 임플란트 및 의료기기와 관련된 감염 위험을 줄이기 위해 항균 특성을 가진 생체적합성 코팅을 개발하려는 추세가 강화되고 있는 것도 시장 성장에 크게 기여하고 있습니다. 은 이온 및 기타 항균제를 함유한 이러한 코팅은 수술 후 합병증을 예방하는 데 매우 중요합니다. 그러나 생체적합성 코팅, 특히 나노기술이나 생리활성물질과 같은 첨단 물질을 포함하는 코팅의 연구개발에 따른 높은 비용이 시장 성장의 걸림돌로 작용하고 있습니다. 이는 생체적합성과 내구성을 겸비한 코팅의 개발이 기술적으로 어렵기 때문입니다. 안정된 필름 두께 확보, 시간 경과에 따른 열화 방지, 원하는 기능적 특성 구현 등의 문제는 특정 코팅의 확장성 및 적용 가능성을 제한할 수 있습니다. 반면, 최소침습 수술의 개발 등 의료기기 설계 및 제조 분야의 혁신은 이러한 기기의 성능과 내구성을 향상시키는 첨단 생체적합성 코팅에 대한 수요를 촉진하고 있습니다. 이러한 신흥 시장 개척은 예측 기간 동안 시장 성장에 유리한 기회를 제공할 것으로 예상됩니다.

세계 생체적합성 코팅 산업은 유형, 재료, 최종사용자 및 지역으로 분류됩니다. 유형별로 시장은 항균성, 친수성, 기타로 세분화됩니다. 재료별로는 폴리머, 세라믹, 금속, 기타로 나뉩니다. 최종사용자별로 헬스케어, 의료기기, 기타로 분류됩니다. 지역별로 시장은 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

주요 조사 결과

유형별로는 항균 코팅 분야가 2024년부터 2033년까지 세계 시장을 장악할 것으로 예상됩니다.

재료별로는 폴리머가 예측 기간 동안 주요 부문으로 부상할 것으로 예상됩니다.

최종사용자별로는 의료기기 분야가 향후 몇 년 동안 괄목할 만한 성장세를 보일 것으로 예상됩니다.

지역별로는 북미가 2023년 매출 기준으로 가장 큰 시장 점유율을 차지했으며, 예측 기간 동안에도 시장을 지배할 것으로 전망됩니다.

본 보고서에서 가능한 커스터마이징(추가 비용 및 일정이 있습니다.)

  • 고객의 관심사에 따른 기업 프로파일 추가
  • 기업 개요 확장 목록
  • 과거 시장 데이터

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

  • 시장 정의와 범위
  • 주요 조사 결과
    • 주요 투자 기회
    • 주요 성공 전략
  • Porter's Five Forces 분석
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 기회

제4장 생체적합성 코팅 시장 : 유형별

  • 시장 개요
  • 항균성
  • 친수성
  • 기타

제5장 생체적합성 코팅 시장 : 재료별

  • 시장 개요
  • 폴리머
  • 세라믹
  • 금속
  • 기타

제6장 생체적합성 코팅 시장 : 최종사용자별

  • 시장 개요
  • 헬스케어
  • 의료기기
  • 기타

제7장 생체적합성 코팅 시장 : 지역별

  • 시장 개요
  • 북미
    • 주요 시장 동향과 기회
    • 미국의 생체적합성 코팅 시장
    • 캐나다의 생체적합성 코팅 시장
    • 멕시코의 생체적합성 코팅 시장
  • 유럽
    • 주요 시장 동향과 기회
    • 프랑스의 생체적합성 코팅 시장
    • 독일의 생체적합성 코팅 시장
    • 이탈리아의 생체적합성 코팅 시장
    • 스페인의 생체적합성 코팅 시장
    • 영국의 생체적합성 코팅 시장
    • 기타 유럽의 생체 적합 코팅 시장
  • 아시아태평양
    • 주요 시장 동향과 기회
    • 중국의 생체적합성 코팅 시장
    • 일본의 생체적합성 코팅 시장
    • 인도의 생체적합성 코팅 시장
    • 한국의 생체적합성 코팅 시장
    • 호주의 생체적합성 코팅 시장
    • 기타 아시아태평양의 생체 적합 코팅 시장
  • 라틴아메리카, 중동 및 아프리카
    • 주요 시장 동향과 기회
    • 브라질의 생체적합성 코팅 시장
    • 남아프리카공화국의 생체적합성 코팅 시장
    • 사우디아라비아의 생체적합성 코팅 시장
    • 기타 라틴아메리카, 중동 및 아프리카의 생체적합성 코팅 시장

제8장 경쟁 상황

  • 소개
  • 주요 성공 전략
  • 주요 10개 기업 제품 매핑
  • 경쟁 대시보드
  • 경쟁 히트맵
  • 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

  • DSM Biomedical B.V.
  • Surmodics, Inc.
  • BASF SE
  • Covalon Technologies Ltd.
  • Harland Medical Systems, LLC
  • Biocoat, Inc.
  • BioInteractions Ltd.
  • AST Products, Inc.
  • PPG Industries
  • Precision Coating Company, Inc.
ksm 24.10.29

The biocompatible coating market was valued at $13.4 billion in 2023, and is projected to reach $41.4 billion by 2033, growing at a CAGR of 12% from 2024 to 2033.

Biocompatible coatings are biomaterials that are applied to medical devices, implants, and other healthcare-related materials to ensure they are compatible with the biological environment of the human body. These coatings are designed to minimize adverse reactions, such as inflammation or rejection, by promoting a harmonious interaction between the device and surrounding tissues. They enhance the performance and longevity of medical implants by imparting properties like anti-corrosion, anti-wear, and bioactivity, making them essential in advancing medical technology and improving patient outcomes.

The growth of the global biocompatible coating market is driven by surge in geriatric population and rise in prevalence of chronic diseases that are leading to increased need for medical implants, such as orthopedic, dental, and cardiovascular devices, which require biocompatible coatings for safe and effective integration with the body. According to the 2022 American Joint Replacement Registry (AJRR) annual report, approximately 2.8 million hip and knee procedures were carried out in the U.S. Moreover, rise in emphasis on reducing the risk of complications, such as infections and implant rejection, is driving the adoption of biocompatible coatings that improve the safety and compatibility of medical devices. Furthermore, the expansion of the pharmaceutical sector and surge in demand for drug delivery systems, which require biocompatible coatings to ensure controlled release and stability of active pharmaceutical ingredients, contribute toward the market growth. Moreover, the growing trend toward developing biocompatible coatings with antimicrobial properties to reduce the risk of infections associated with medical implants and devices is significantly fostering the market growth. These coatings, incorporating silver ions or other antimicrobial agents, are crucial in preventing postoperative complications. However, high cost associated with R&D of biocompatible coatings, especially those incorporating advanced materials like nanotechnology or bioactive substances, hampers the market growth. This is attributed to the fact that developing coatings that are both biocompatible and durable is technically challenging. Issues such as ensuring consistent coating thickness, preventing degradation over time, and achieving the desired functional properties can limit the scalability and applicability of certain coatings. On the contrary, innovations in medical device design and manufacturing, including the development of minimally invasive procedures, are driving the demand for advanced biocompatible coatings that enhance the performance and durability of these devices. Such developments are expected to offer lucrative opportunities for the market growth during the forecast period.

The global biocompatible coating industry is segmented into type, material, end user, and region. On the basis of type, the market is fragmented into antimicrobial, hydrophilic, and others. Depending on material, it is divided into polymer, ceramic, metal, and others. As per end user, it is segregated into healthcare, medical device, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the antimicrobial coatings segment is expected to dominate the global market from 2024 to 2033.

Depending on material, polymers is anticipated to emerge as a leading segment during the forecast period.

As per end user, the medical device segment is projected to exhibit notable growth in the coming years.

Region wise, North America held the largest market share in terms of revenue in 2023, and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global biocompatible coating market include DSM Biomedical B.V., Surmodics, Inc., BASF SE, Covalon Technologies Ltd., Harland Medical Systems, LLC, Biocoat, Inc., BioInteractions Ltd., AST Products, Inc., PPG Industries, and Precision Coating Company, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type

  • Antimicrobial
  • Hydrophilic
  • Others

By Material

  • Polymer
  • Ceramic
  • Metal
  • Others

By End User

  • Healthcare
  • Medical Device
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • DSM Biomedical B.V.
    • Surmodics, Inc.
    • BASF SE
    • Covalon Technologies Ltd.
    • Harland Medical Systems, LLC
    • Biocoat, Inc.
    • BioInteractions Ltd.
    • AST Products, Inc.
    • PPG Industries
    • Precision Coating Company, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BIOCOMPATIBLE COATING MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Antimicrobial
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Hydrophilic
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BIOCOMPATIBLE COATING MARKET, BY MATERIAL

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Material
  • 5.2. Polymer
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ceramic
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Metal
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: BIOCOMPATIBLE COATING MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Healthcare
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Medical Device
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: BIOCOMPATIBLE COATING MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Material
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Biocompatible Coating Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Material
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Biocompatible Coating Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Material
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Biocompatible Coating Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Material
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Material
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Biocompatible Coating Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Material
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Biocompatible Coating Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Material
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Biocompatible Coating Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Material
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Biocompatible Coating Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Material
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Biocompatible Coating Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Material
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Biocompatible Coating Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Material
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Material
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Biocompatible Coating Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Material
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Biocompatible Coating Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Material
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Biocompatible Coating Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Material
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Biocompatible Coating Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Material
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Biocompatible Coating Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Material
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Biocompatible Coating Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Material
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Material
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Biocompatible Coating Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Material
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Biocompatible Coating Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Material
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Biocompatible Coating Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Material
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Biocompatible Coating Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Material
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. DSM Biomedical B.V.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Surmodics, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. BASF SE
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Covalon Technologies Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Harland Medical Systems, LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Biocoat, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. BioInteractions Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. AST Products, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. PPG Industries
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Precision Coating Company, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제